Effect of Apollo Wearable on Long COVID-19 Symptoms.

NCT06097442 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-10-27

No results posted yet for this study

Summary

The purpose of this study is to examine how Apollo wearable use impacts symptoms and quality of life following long COVID.

Conditions

  • Post-acute Sequelae of SARS-COV-2 Infection

Sponsors & Collaborators

  • Apollo Neuroscience, Inc.

    collaborator INDUSTRY
  • The Board of Medicine

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-23
Primary Completion
2024-12-31
Completion
2025-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06097442 on ClinicalTrials.gov